Eli Lilly: 45 to 1 – A Data-Science Valuation Brief
On 3/13/24, Eli Lilly’s price to sales ratio was 21. In the last 9,919 trading days (40 years), Lilly had a P/S of 3.6 or less on 3,715 days (37.4%). In the future, Lilly will again have a P/S ratio substantially less than 4. What does imply for Lilly’s price?